In Total Ankle Replacement (TAR), there has been a renaissance of interest in recent years. Relieving arthritic pain and restoring range of motion is the success of third-generation implant has poised TAR as a good substitute to arthrodesis.The previous generation devices, there was intensive bone resection but now current products are manufactured with the objective to minimize resection of the tibial and talar bone to implant stability. To accomplish enhanced and accurate arrangement, there is advancement in preoperative evaluation techniques by manufacturers. Recently, there is a rise in utilization TAR based on positive study from long-term mobility trails and advancement in implant design because ankle trauma is not common as knee and hip joint and other joints. To support patient’s access to TAR, major insurer has revised its policy. Hospitals are taking steps to minimize the cost with the help of physicians because implant cost comprises of a part of operating cost of room supply in an orthopedic procedure.
According to the market research report “MediPoint: Total Ankle Replacement-South America Analysis and Market Forecasts“, in developing and developed economies, there is a swell in devitalize and severe problem of ankle and arthritis. This is due to seeking out the modern life style like sport related injuries, aging, obesity and trauma. TAR has become most promising option for late-stage ankle arthritics patience, with an alternative of ankle fusion, after so many years or trial and error.
In 2016, the South America has shown promising escalation in market, which is estimated to be of around $3.1 million. Argentina, Brazil and Chile have been projected to growth manifold in future. There will be increase in TAR patience because of wear and tear of aging joints. There will be an increase in last-stage ankle arthritics problem. The key driver of TAR market in South America is expanded medical education and surgeon in forecast period. There are few chief players in TAR market, which are- Stryker, Integra Lifesciences, Wright medical, DePuy Synthes and Zimmer Biomet. With momentous clinical research data driving product adoption, these companies boast the reputable brands. TAR does not attract competitors as it is not so profitable and the new entrants are prohibited for getting a device in market. Therefore, the major players only have the market share with them and they will continue to enhance their product mix.
There has been encroachment in ankle implant design. With an introduction to bone sparing, it is a low profile design that allows the surgeon to retain more of the natural bone than the other implants. It works together to restore the natural movement of the ankle joint. It tendons to help and regain the normal walking gait and provides integrated movement with muscles. Number of sizing options and allowance to choose the closest fit to ankle anatomy is offered by TAR system. There is development of new material, which is resistant to wear. It also has intended to provide durability in the replacement of ankle joint. The advanced implant material is not a coating, it is a three- dimension advanced structure, which is like a porous structure of natural cancellous bone.
For further reading click on the link below:
https://www.kenresearch.com/healthcare/medical-devices/medipoint-total-ankle-replacement-south-america/110223-91.html
Related reports:
Thoracic Aortic Stent Grafts-Medical Devices Pipeline Assessment, 2017
Interventional Neurology-Medical Devices Pipeline Assessment, 2017
Contact:
Ken Research
Ankur Gupta, Head Marketing & Communications
query@kenresearch.com
+91-124-4230204
